Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
243
NCT03078738
Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 8, 2017
Completion: Mar 12, 2018
NCT03906799
Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
Phase: Phase 2
Start: Mar 19, 2019
Completion: Mar 20, 2020
NCT05972954
OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)
Start: May 22, 2023
Completion: Jun 30, 2025